Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease

被引:26
|
作者
Bouabdallaoui, Nadia [1 ]
Messas, Nathan [1 ]
Greenlaw, Nicola [2 ]
Ferrari, Roberto [3 ,4 ]
Ford, Ian [2 ]
Fox, Kim M. [5 ,6 ]
Tendera, Michal [7 ]
Naidoo, Datshana P. [8 ]
Hassager, Christian [9 ,10 ]
Steg, P. Gabriel [11 ]
Tardif, Jean-Claude [1 ]
机构
[1] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Univ Ferrara, Cardiovasc Ctr, Cotignola, Italy
[4] Maria Cecilia Hosp, Cotignola, Italy
[5] Imperial Coll, Natl Heart & Lung Inst, London, England
[6] Royal Brompton Hosp, London, England
[7] Med Univ Silesia, Sch Med Katowice, Dept Cardiol & Struct Heart Dis, Katowice, Poland
[8] Univ KwaZulu Natal, Sch Pharm & Pharmacol, Durban, South Africa
[9] Univ Copenhagen, Rigshosp, Dept Cardiol, Copenhagen, Denmark
[10] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[11] Univ Paris, Assistance Publ Hop Paris, Paris, France
关键词
Smoking; coronary artery disease; outcomes; mortality; RISK; ATORVASTATIN; OUTPATIENTS; TOBACCO;
D O I
10.1177/2047487320918728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Smoking is a major preventable risk factor for cardiovascular disease and mortality. However, the 'smoker's paradox' suggests that it is associated with better survival after acute myocardial infarction. We aimed to investigate the impact of smoking on mortality and cardiovascular outcomes in patients with stable coronary artery disease. Methods The international CLARIFY registry included 32,703 patients with stable coronary artery disease between 2009 and 2010. Among the 32,378 patients included in the present analysis, Cox proportional hazards models (adjusted for age, sex, geographic region, prior myocardial infarction, and revascularization status) were used to estimate associations between smoking status and outcomes. Patients were stratified as follows: 41.3% of patients never smoked, 12.5% were current smokers and 46.2% were former smokers. Results Current smokers were younger than never-smokers and former smokers (59 vs. 66 and 64 years old, respectively, p < 0.0001). There were more men among current or former smokers compared with never-smokers. Compared with never-smokers, both current and former smokers were at higher risk of all-cause death (hazard ratio = 1.96 and 1.37) and cardiovascular death (hazard ratio = 1.92 and 1.38) within five years (all p < 0.05). Similarly graded and increased risks were present for myocardial infarction and the composite of cardiovascular death, myocardial infarction and stroke (all p < 0.05). Conclusion In contrast to the 'smoker's paradox', current smokers with stable coronary artery disease have a greatly increased risk of future cardiovascular events, including mortality, compared with never-smokers. In former smokers, cardiovascular risk remains elevated albeit at an intermediate level between that of current and never-smokers, reinforcing the importance of smoking cessation. (ISRCTN43070564).
引用
收藏
页码:1460 / 1466
页数:7
相关论文
共 50 条
  • [1] Impact of Geriatric Nutritional Risk Index on cardiovascular outcomes in patients with stable coronary artery disease
    Kunimura, Ayako
    Ishii, Hideki
    Uetani, Tadayuki
    Aoki, Toshijirou
    Harada, Kazuhiro
    Hirayama, Kenshi
    Negishi, Yosuke
    Shibata, Yohei
    Sumi, Takuya
    Kawashima, Kazuhiro
    Tatami, Yosuke
    Kawamiya, Toshiki
    Yamamoto, Dai
    Suzuki, Susumu
    Amano, Tetsuya
    Murohara, Toyoaki
    JOURNAL OF CARDIOLOGY, 2017, 69 (1-2) : 383 - 388
  • [2] Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease
    Leu, Hsin-Bang
    Yin, Wei-Hsian
    Tseng, Wei-Kung
    Wu, Yen-Wen
    Lin, Tsung-Hsien
    Yeh, Hung-I.
    Chang, Kuan-Cheng
    Wang, Ji-Hung
    Wu, Chau-Chung
    Chen, Jaw-Wen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (03) : 721 - 729
  • [3] Immature platelets and cardiovascular events in patients with stable coronary artery disease
    Pedersen, Oliver Buchhave
    Larsen, Sanne Bojet
    Kristensen, Steen Dalby
    Hvas, Anne-Mette
    Grove, Erik Lerkevang
    PLATELETS, 2023, 34 (01)
  • [4] Lipoprotein (a), hypertension, and cardiovascular outcomes: a prospective study of patients with stable coronary artery disease
    Liu, Hui-Hui
    Cao, Ye-Xuan
    Jin, Jing-Lu
    Hua, Qi
    Li, Yan-Fang
    Guo, Yuan-Lin
    Zhu, Cheng-Gang
    Wu, Na-Qiong
    Dong, Qian
    Li, Jian-Jun
    HYPERTENSION RESEARCH, 2021, 44 (09) : 1158 - 1167
  • [5] Impact of nutritional assessment and body mass index on cardiovascular outcomes in patients with stable coronary artery disease
    Kunimura, Ayako
    Ishii, Hideki
    Uetani, Tadayuki
    Aoki, Toshijirou
    Harada, Kazuhiro
    Hirayama, Kenshi
    Negishi, Yosuke
    Shibata, Yohei
    Sumi, Takuya
    Kawashima, Kazuhiro
    Tatami, Yosuke
    Kawamiya, Toshiki
    Yamamoto, Dai
    Suzuki, Susumu
    Amano, Tetsuya
    Murohara, Toyoaki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 230 : 653 - 658
  • [6] Impact of shisha smoking on the extent of coronary artery disease in patients referred for coronary angiography
    Selim, Ghada M.
    Fouad, Hany
    Ezzat, Samy
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2013, 13 (07) : 647 - 654
  • [7] The clinical significance of osteopontin on the cardiovascular outcomes in patients with stable coronary artery disease
    Cheong, Kei-Ip
    Leu, Hsin-Bang
    Wu, Chau-Chung
    Yin, Wei-Hsian
    Wang, Ji-Hung
    Lin, Tsung-Hsien
    Tseng, Wei-Kung
    Chang, Kuan-Cheng
    Chu, Shu-Hsun
    Yeh, Hung-, I
    Chen, Jaw-Wen
    Wu, Yen-Wen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (04) : 328 - 337
  • [8] Impact of diabetes and hypertension on cardiovascular outcomes in patients with coronary artery disease receiving percutaneous coronary intervention
    Lin, Mao-Jen
    Chen, Chun-Yu
    Lin, Hau-De
    Wu, Han-Ping
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [9] Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension
    Vidal-Petiot, Emmanuelle
    Greenlaw, Nicola
    Ford, Ian
    Ferrari, Roberto
    Fox, Kim M.
    Tardif, Jean-Claude
    Tendera, Michal
    Parkhomenko, Alexander
    Bhatt, Deepak L.
    Steg, P. Gabriel
    HYPERTENSION, 2018, 71 (01) : 168 - 176
  • [10] Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease
    Liu, Shuo-Lin
    Wu, Na-Qiong
    Shi, Hui-Wei
    Dong, Qian
    Dong, Qiu-ting
    Gao, Ying
    Guo, Yuan-Lin
    Li, Jian-Jun
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)